PASS-01 Announcement: A Message from Michelle Capobianco

PASS-01 Announcement: A Message from Michelle Capobianco

Today I am thrilled to announce the launch of our next landmark research investment, PASS-01: a clinical trial that will finally address the diverse nature of this disease and provide personalized treatment options for advanced pancreatic cancer patients....
Alex Trebek’s Death and the Need for Research

Alex Trebek’s Death and the Need for Research

Alex Trebek’s Death and the Need for Innovative Research: 900CHML Pancreatic Cancer Canada CEO Michelle Capobianco speaks with 900CHML host Scott Thompson about Alex Trebek’s passing to stage IV pancreatic cancer, the need for public awareness and...